VeriMomeucalyptus globulus leaf extract est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classification found and no CIR or SCCS safety assessment identifying reproductive hazard for Eucalyptus globulus leaf extract. Peer‑reviewed literature does not show confirmed teratogenic or reproductive effects for the botanical extract at typical topical exposure levels; however constituents (e.g., 1,8‑cineole in eucalyptus oil) can be systemically absorbed, so low but measurable maternal exposure from topical use is plausible (sources: ECHA Annex VI (no harmonised reproductive flag), CIR (no assessment flagged), PubMed literature on eucalyptus/1,8‑cineole).
Pregnancy-safe products containing eucalyptus globulus leaf extract
Related ingredients
Frequently asked questions
- eucalyptus globulus leaf extract est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification found and no CIR or SCCS safety assessment identifying reproductive hazard for Eucalyptus globulus leaf extract. Peer‑reviewed literature does not show confirmed teratogenic or reproductive effects for the botanical extract at typical topical exposure levels; however constituents (e.g., 1,8‑cineole in eucalyptus oil) can be systemically absorbed, so low but measurable maternal exposure from topical use is plausible (sources: ECHA Annex VI (no harmonised reproductive flag), CIR (no assessment flagged), PubMed literature on eucalyptus/1,8‑cineole).
- eucalyptus globulus leaf extract est-il sûr pendant l'allaitement ?
- No evidence of reproductive or lactation-specific toxicity or harmonised classification. Systemic absorption of volatile constituents is possible after topical application, so low but measurable exposure to lactating parent is plausible; no data indicate transfer to breastmilk or harmful effects in breastfed infants (sources: PubChem, PubMed, absence of ECHA harmonised classification).
- eucalyptus globulus leaf extract est-il sûr pour la peau de bébé ?
- No specific data showing developmental or reproductive toxicity in infants from topical cosmetic use of the leaf extract and no harmonised CLP reproductive hazard. However, infant skin has higher permeability and eucalyptus materials (notably eucalyptus oil/1,8‑cineole) are reported in the literature to cause adverse effects in young children when ingested or used inappropriately; therefore dermal exposure is judged as moderate (adult exposure scored as low measurable, increased by +1 for infants). No infant‑specific mechanistic evidence of reproductive endocrine disruption was found (sources: PubMed reports of pediatric toxicity from eucalyptus oil ingestion, EWG entries; no ECHA Annex VI reproductive flags).
- Comment VeriMom évalue-t-il eucalyptus globulus leaf extract ?
- VeriMom évalue eucalyptus globulus leaf extract à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à eucalyptus globulus leaf extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à eucalyptus globulus leaf extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.